NEW YORK , Aug. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Replimune Group, Inc. (NASDAQ: REPL). Shareholders who purchased shares of REPL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

NEW YORK , Aug. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Alto Neuroscience, Inc. (NYSE: ANRO). Shareholders who purchased shares of ANRO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

NEW YORK , Aug. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Shareholders who purchased shares of HIMS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

NEW YORK , Aug. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Flywire Corporation (NASDAQ: FLYW). Shareholders who purchased shares of FLYW during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

NEW YORK , Aug. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of RxSight, Inc. (NASDAQ: RXST). Shareholders who purchased shares of RXST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

NEW YORK , Aug. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Sarepta Therapeutics, Inc. (NASDAQ: SRPT). Shareholders who purchased shares of SRPT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

Astera Labs delivered outstanding Q2 FY2025 results, with broad-based revenue growth across key product lines and upside versus guidance. AI infrastructure demand, expanding product portfolio, and deep hyperscaler relationships position Astera for continued rapid growth and market share gains. Upcoming H2 FY2025 product launches are set to unlock a major revenue ramp, with all four product families shipping in meaningful volumes.

LOS ANGELES , Aug. 11, 2025 /PRNewswire/ -- News provided by DJS Law Group LLP The DJS Law Group reminds investors that it is investigating claims against Fluor Corporation ("Fluor" or "the Company") (NYSE: FLR) for violations of securities laws. The investigation centers on whether the Company made false and/or misleading statements or omitted information critical to investors.

YOQNEAM, Israel, Aug. 11, 2025 (GLOBE NEWSWIRE) -- MIND C.T.I. LTD. – (NasdaqGM:MNDO), a leading provider of convergent end-to-end prepaid/postpaid billing and customer care product-based solutions for service providers, unified communications (UC) analytics and call accounting solutions for enterprises as well as enterprise messaging solutions, today announced results for its second quarter ended June 30, 2025.

American Resources Corp (NASDAQ:AREC), through its holding in ReElement Technologies, announced it has developed commercial protocols to produce germanium with purities exceeding 99.9% from both recycled and ore-based feedstocks. The company's process is designed to supply commercial and defense markets requiring germanium products with purities ranging from 99.9% to 99.999%.

LOS ANGELES , Aug. 11, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ: CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 9, 2024, and July 10, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before September 15, 2025.

Dynavax delivered strong Q2 results, beating expectations and narrowing guidance, and Heplisav-B continued to sport market share gains and profitability. Heplisav-B is best-in-class in its niche, and management is projecting significant sales and market share growth through 2030. Dynavax boasts a robust balance sheet, recently completed a $200M buyback, and is well-regarded by analysts, supporting further accumulation at current valuations.

LOS ANGELES , Aug. 11, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Sarepta Therapeutics, Inc. ("Sarepta" or "the Company") (NASDAQ: SRPT) for violations of the federal securities laws. Shareholders who purchased the Company's securities between June 22, 2023 and June 24, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before August 25, 2025.

WOOD DALE, Ill., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Power Solutions International, Inc. (“PSI” or the “Company”) is excited to announce a significant financial milestone. On July 30, 2025, PSI entered into a Second Amendment (the “Amendment”) to its existing Uncommitted Revolving Credit Agreement with Standard Chartered Bank, acting as administrative agent alongside participating lenders (collectively, the “Lenders”). This newly Amended Credit Agreement increases PSI's committed borrowing capacity to $135.0 million, providing enhanced flexibility and strategic firepower to support our continued growth and innovation. The agreement now extends through July 30, 2027, solidifying our financial foundation for the next two …

LOS ANGELES , Aug. 11, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against RxSight, Inc. ("RxSight" or "the Company") (NASDAQ: RXST) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 7, 2024 and July 8, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before September 22, 2025.

Long-term dividend plays tend to be more stable than many other stocks—after all, this stability is why they are able to provide consistent dividends in the first place. Traditional dividend stocks are large, well-established companies that are unlikely to experience significant volatility apart from trends affecting the broader market.

LOS ANGELES , Aug. 11, 2025 /PRNewswire/ -- The DJS Law Group reminds investors that it is investigating claims against Lineage, Inc. ("Lineage" or "the Company") (NASDAQ: LINE) for violations of securities laws. Shareholders who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents issued in connection with its initial public offering ("IPO") conducted in July 2024, should contact the firm before September 30, 2025 The investigation alleges that the Company communicated false and misleading information to the market.

JHG, GBX, PDS, MOS, and PAGS boast low price-to-sales ratios, meeting strict value screens for strong upside potential.

LOS ANGELES , Aug. 11, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Lineage, Inc. ("Lineage" or "the Company") (NASDAQ: LINE) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents issued in connection with its initial public offering ("IPO") conducted in July 2024, are encouraged to contact the firm before September 30, 2025.

The summer months and October are known being tough on stocks, but seasonal trends don't always repeat. Even when they do, it's not necessarily a call for long-term investors to move away from equities.